The U.S. cell separation market size was estimated at USD 3.30 billion in 2023 and is expected to grow CAGR of 7.7% from 2024 to 2030. Cell separation plays a crucial role in different applications such as in-vitro diagnostics, biologics designing and development, therapeutic protein production, and other research applications.

Increasing prevalence of chronic diseases, such as cancer, and extensive RD activities by key companies to develop novel cell gene therapies are expected to fuel the demand for cell separation solutions. As per the American Cancer Society’s estimates, in 2021, around 1.9 million new cases of cancer were estimated to be diagnosed in the U.S., with over 608,570 cancer-related deaths. Biologics is recognized as the fourth major method to treat cancer efficiently.

Furthermore, biologics play a key role in the development of precision medicines. The U.S. has seen significant growth in biologics in recent years. It has exported 6,355 patents to China, 11,742 to Japan, and 72 to Germany over the past three decades. As a result, around 15 new biologics were approved by the U.S. FDA in 2022, including cancer therapeutics such as Kimmtrak, Opdualag, and Imjudo.

In 2023, the U.S. cell separation market accounted for over 36% of the global cell separation market. The presence of major companies such as Thermo Fisher Scientific, BD, Danaher in the country and their strategic initiatives are anticipated to fuel the market growth. For instance, in February 2021, Thermo Fisher Scientific acquired cell sorting assets from Propel Labs. As per the deal, the company added a new Bigfoot Spectral Cell Sorter of Propel Labs to its capabilities.

U.S. Cell Separation Market Report Highlights

• Consumables antibodies held the largest share of 60.2% in 2023 and this is also expected to witness the fastest growth rate over the forecast period. T
• Animal cells held the largest market share of 52.4% in 2023. Drug discovery and development involve the use of animal cells to examine preliminary toxicity, efficacy, and pharmacokinetics of new drug molecules. 
• Centrifugation held the largest market share of 40.6% in 2023. Cell separation often involves the use of differential centrifugation and density gradient centrifugation.
• Biotechnology and biopharmaceutical companies occupied the largest revenue share of 42.1% in 2023. The segment is also expected to exhibit the fastest growth rate during the forecast period.

U.S. Cell Separation Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. cell separation market report based on product, cell type, technique, application, and end-use.

• Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Consumables
    • Reagents, Kits, Media, and Sera
    • Beads
    • Disposables
  • Instruments
    • Centrifuges
    • Flow Cytometers
    • Filtration Systems
    • Magnetic-activated Cell Separator Systems
  • Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Human Cells
    • Animal Cells
  • Technique Outlook (Revenue, USD Million, 2018 - 2030)
    • Centrifugation
    • Surface Marker
    • Filtration
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Biomolecule Isolation
    • Cancer Research
    • Stem Cell Research
    • Tissue Regeneration
    • In Vitro Diagnostics
    • Therapeutics
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Research Laboratories and Institutes
    • Biotechnology and Biopharmaceutical Companies
    • Hospitals and Diagnostic Laboratories
    • Cell Banks

Order a free sample PDF of the U.S. Cell Separation Market Intelligence Study, published by Grand View Research.